StockNews.com Initiates Coverage on Ampio Pharmaceuticals (NYSE:AMPE)

Equities researchers at StockNews.com assumed coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE) in a research note issued on Sunday. The brokerage set a “sell” rating on the stock.

Ampio Pharmaceuticals Price Performance

Shares of AMPE stock opened at $0.00 on Friday. Ampio Pharmaceuticals has a 52 week low of $0.00 and a 52 week high of $1.99. The company has a market capitalization of $2,383.50, a price-to-earnings ratio of 0.00 and a beta of 3.78.

About Ampio Pharmaceuticals

Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.